XML 77 R3.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Deferred financing costs $ 18,031 $ 17,555
Deferred financing costs $ 7,452 $ 0
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 50,000,000 50,000,000
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 450,000,000 450,000,000
Common stock, shares issued (in shares) 153,531,756 133,853,565
Common stock, shares outstanding (in shares) 153,531,756 133,853,565
Series B Preferred Stock    
Preferred stock, shares issued (in shares) 6,770,393 6,770,393
Preferred stock, shares outstanding (in shares) 6,770,393 6,770,393
Preferred stock, liquidation preference $ 169,260 $ 169,260
Series C Preferred Stock    
Preferred stock, shares issued (in shares) 0 6,900,000
Preferred stock, shares outstanding (in shares) 0 6,900,000
Preferred stock, liquidation preference $ 0 $ 172,500
Commercial Mortgage Portfolio Segment    
Loans pledged as collateral $ 4,118,926 $ 3,197,900